If a supplied lot fails agreed specifications, we’ll replace it at no cost or refund its purchase price in full.
Quality test failed? Free replacement or full refund.
Off-spec? Free replacement or full refund.
Reading a Peptide HPLC Trace — A 5-Minute Field Guide for Bench Scientists. Read our briefing →
Reading a peptide HPLC trace — a field guide. Read →
On reading HPLC traces. Read →
Reference standard · Research use only
Also known as TB-500 · Thymosin beta-4 (full-length) · Thymosin Beta-4 · Thymosin β4 · Tβ4 · TB4 · TB-4 · TB500 · Timbetasin
Full-length Thymosin β4 (43 residues)
Price, MOQ and lead time come in your written quote — usually within 24 hours. No account needed.
Compound facts
| Name | TB-500 (Thymosin Beta-4, full-length) |
|---|---|
| Also known as | TB-500 · Thymosin beta-4 (full-length) · Thymosin Beta-4 · Thymosin β4 · Tβ4 · TB4 · TB-4 · TB500 · Timbetasin |
| CAS number | 77591-33-4 |
| PubChem CID | 16132341 |
| Molecular formula | C212H350N56O78S |
| Molecular weight | 4963.51 g/mol |
| Sequence | SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES |
| Appearance | White to off-white lyophilized powder |
| Purity specification (HPLC) | ≥ 99.0% |
| On every batch COA | RP-HPLC purity · ESI-MS identity · Bacterial endotoxin · Fill amount (content per vial) |
| On request | LC-MS/MS sequence confirmation · Net peptide content · Water content (Karl Fischer) · Counter-ion content (e.g. acetate, TFA) · Microbial limits |
| Storage | 2–8°C, protect from light |
| Strengths per vial | 2 mg · 5 mg · 10 mg · 20 mg |
| Pack | 10 vials per kit |
| MOQ | On request |
| Lead time | 7–14 days |
| Use | Research use only — not for human or veterinary use |
Identity data from the Lyochem product catalogue, checked against PubChem and registry records. The batch COA of your lot is the record for that lot's results. How to verify a COA
Lot documentation
Values belong to the lot. Ask for the COA of the offered lot before you order.
Each picture is a low-resolution preview of a report's first page, with batch and report numbers covered. For the full, clear report, ask our sales team, naming the product and strength.
Third-party reportTB-500 / Thymosin beta-4 10 mg
HPLC purity · MS identity
Third-party laboratory, Tianjin, China
Full, clear copy from sales
Independent test fails? Full refund. How it works
Research documentation
Before qualifying TB-500 as a research reference lot, review the labelled sequence, HPLC purity, mass identity, matching lot COA, and storage conditions. Confirm whether your study needs additional sequence evidence.
Overview
TB-500 here is synthetic full-length Thymosin β4, the 43-residue, N-terminally acetylated actin-sequestering protein present in nearly all mammalian cells. It is not the seven-residue Ac-LKKTETQ fragment (residues 17–23), which is listed separately as TB-500 (fragment 17-23). Its activity turns on actin binding through the central LKKTETQ motif, which propagates into effects on cell migration, angiogenesis, and tissue regeneration, the foundation for its extensive research record in wound-healing, cardiac-remodeling, and tendon-ligament repair models. Longer than BPC-157, the peptide is serum-stable yet lacks oral bioavailability, confining research protocols to injectable administration. Its tissue-repair literature has drawn US regulatory attention, notably at the July 2026 FDA Pharmacy Compounding Advisory Committee meeting, but that discussion leaves Lyochem's Research-Use-Only scope unchanged. Lyochem supplies TB-500 acetate as a lyophilized reference standard to a ≥99.0% HPLC purity specification. The 43-mer sits in the upper-middle range for routine SPPS, dependable to make but requiring more purification cycles than shorter sequences like BPC-157, so release leans on peak-integration HPLC plus mass spec to resolve near-coeluting deletion sequences. For a peptide this length, mass alone carries more identity ambiguity than for a 15-mer, which is why LC-MS/MS sequence verification is the qualification test we recommend for any TB-500 lot. Ordering options cover the individual vial and the co-formulated Wolverine Blend pairing it with BPC-157 (standard 5+5 mg per 10 mg vial; custom ratios via Lyochem's custom-synthesis programme).
Applications & buyer fit
Repair peptides — BPC-157, TB-500, PEG-MGF — ship primarily to research laboratories. The applicable batch COA records the tests actually completed. Tandem-MS sequence evidence is an additional agreed scope when the buyer's written procedure requires it, not a blanket requirement to repeat release testing.
Biotech R&D Groups
Preclinical biotech and pharmaceutical discovery teams sourcing characterized peptides for receptor-pharmacology, screening, and method-development campaigns.
Academic Laboratories
Universities, medical schools, and government research institutes qualifying a reference standard for a method-development or in vivo workflow.
Every lot has its own batch-specific CoA — RP-HPLC purity, ESI-MS identity, bacterial endotoxin and fill amount, plus any analytical scope agreed at quote stage — tied to the exact lot you receive.
Review a representative batch CoA before you order, so you can confirm the packet matches what your method or sponsor audit needs.
Supplied strictly as a research reagent to research institutions — not a finished dosage form and not for human administration. Buyer qualification runs at the inquiry stage.
Other formats

TB-500 (Thymosin Beta-4, full-length) is also kept as a solution in nasal spray bottles.
| Contents | 2 mg, 5 mg, 10 mg |
|---|---|
| Fill volume | 10 mL or 20 mL |
| Minimum | 10 bottles per content and volume |
| Stock | Held in the United States, shipped within the US |
Regulatory note
TB-500 has been the subject of US regulatory discussion in compounding-pharmacy contexts; Lyochem supplies it strictly for Research Use Only and does not opine on the destination market's specific eligibility.
Selected literature
Frequently asked questions
Purity is read from the RP-HPLC main-peak area; identity is a separate question. ESI-MS fixes the intact mass but, on a peptide this long, cannot separate two deletion variants of identical residue mass that differ only in position. That gap is closed by LC-MS/MS, whose b- and y-ion ladder reads the actual residue order and demonstrates the LKKTETQ actin-binding motif is present and correctly placed. A complete packet therefore reports HPLC for purity, ESI-MS for mass, and, at supplier qualification, fragment coverage for sequence.
A single co-lyophilized vial mixes two peptides with different masses and different chromatographic retention, so both must resolve on the analytical run. RP-HPLC separates the two peaks and integrates each, ESI-MS confirms both molecular masses independently, and the certificate reports each component against its labelled fill so the stated 5+5 mg ratio is verifiable rather than assumed. Because water and counter-ion apply to the combined solid, the packet should express content net of both, letting a lab reconstitute to defined molar concentrations of each peptide.
Yes: 2 mg, 5 mg, 10 mg, in 10 mL or 20 mL bottles, minimum 10 bottles per content and volume. This format is held in the United States and shipped within the US; contact sales for availability and a quotation.
Send any vial from your order to an independent laboratory of your choice. If the report shows the product does not meet the specification on its COA — purity below the stated minimum, or an identity that does not match — share the report with our sales team and we refund that product in full.
Related peptides
15-mer
Body Protection Compound 15-mer
Also in nasal sprayAlso in capsules
Co-characterized tissue-repair pairing (BPC-157 + TB-500)
Thymosin β4 (TB-500) fragment preparation · actin-binding region